Abstract
Many contributions have been shown for new drug launch by drug delivery research and development in pharmaceutical companies. These come from long effort by their scientists and make scientist in other department and top management understand their approaches and idea, and also they have answered their expectation. DDS is used to make recognition of their effort. Whereas, business of DDS companies are now in somehow more difficult to create new products because of longer development time and higher cost. Specialty pharma is highlighted because of their approach and strategy.
